These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30873476)

  • 21. Patenting and licensing of university-based genetic inventions--a view from experience at Stanford University's Office of Technology Licensing.
    Leute K
    Community Genet; 2005; 8(4):217-22. PubMed ID: 16244475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Intellectual property in natural sciences].
    Twardowski T
    Postepy Biochem; 2008; 54(1):20-3. PubMed ID: 18610578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. From academic laboratory to the market: Disclosed and undisclosed narratives of commercialization.
    Sapir A; Oliver AL
    Soc Stud Sci; 2017 Feb; 47(1):33-52. PubMed ID: 28195026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Scientific and technological innovation and achievement transformation promote the medical development].
    Zheng MH; Sun J; Jiang TY; Ma JJ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jun; 23(6):541-544. PubMed ID: 32521971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The EAES intellectual property awareness survey.
    Nakajima K; Mintz Y; Nickel F; Arezzo A;
    Surg Endosc; 2022 May; 36(5):3340-3346. PubMed ID: 34363113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patents and the supply of therapeutic products.
    Hayhurst WL
    Law Med Health Care; 1992; 20(3):235-7. PubMed ID: 1434767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New ways of insulin delivery.
    Heinemann L
    Int J Clin Pract Suppl; 2010 Feb; (166):29-40. PubMed ID: 20377662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patents and the nurse scholar, Part I: The basic philosophy of intellectual property.
    Stevens KR
    Reflections; 1994; 20(3):36-8. PubMed ID: 7920108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Short Introduction to Intellectual Property Rights.
    Voss T; Paranjpe AS; Cook TG; Garrison NDW
    Tech Vasc Interv Radiol; 2017 Jun; 20(2):116-120. PubMed ID: 28673648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug development for cryptococcosis treatment: what can patents tell us?
    Santos-Gandelman J; Machado-Silva A
    Mem Inst Oswaldo Cruz; 2019 Jan; 114():e180391. PubMed ID: 30726342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intellectual property rights, standards and data exchange in systems biology: Reflections from the IP Expert Meeting at the University of Luxembourg, 8-9 October 2015, ERASysAPP - ERA-Net for Systems Biology Applications.
    van Zimmeren E; Rutz B; Minssen T
    Biotechnol J; 2016 Dec; 11(12):1477-1480. PubMed ID: 27966844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Legal protection of inventions within medical practice in Ukraine.
    Bezpalova ОI; Yusupov VA; Avramova OY; Krasiuk TV; Larina NB
    Wiad Lek; 2019; 72(3):484-488. PubMed ID: 31051002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. University-based science and biotechnology products: defining the boundaries of intellectual property.
    Kesselheim AS; Avorn J
    JAMA; 2005 Feb; 293(7):850-4. PubMed ID: 15713775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patenting and licensing in genetic testing: recommendations of the European Society of Human Genetics.
    Aymé S; Matthijs G; Soini S;
    Eur J Hum Genet; 2008 May; 16 Suppl 1():S10-9. PubMed ID: 18432281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biomedical device innovation methodology: applications in biophotonics.
    Beswick DM; Kaushik A; Beinart D; McGarry S; Yew MK; Kennedy BF; Maria PLS
    J Biomed Opt; 2017 Dec; 23(2):1-7. PubMed ID: 29243414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using the written description requirement to limit broad patent scope, allow competition, and encourage innovation in biotechnology.
    Mull WC
    Health Matrix Clevel; 2004; 14(2):393-435. PubMed ID: 15503695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The commercialization of human stem cells: ethical and policy issues.
    Resnik DB
    Health Care Anal; 2002; 10(2):127-54. PubMed ID: 12216741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Industry-university collaborations in Canada, Japan, the UK and USA--with emphasis on publication freedom and managing the intellectual property lock-up problem.
    Kneller R; Mongeon M; Cope J; Garner C; Ternouth P
    PLoS One; 2014; 9(3):e90302. PubMed ID: 24632805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Navigating the Murky Waters of Conflict of Interest: Searching for the Middle Path.
    Zonia SC
    J Empir Res Hum Res Ethics; 2016 Feb; 11(1):67-71. PubMed ID: 27106892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of the legal regime of intellectual property protection in the pharmaceutical market.
    Pashkov VM; Golovanova IA; Olefir AA
    Wiad Lek; 2016; 69(3 pt 2):582-586. PubMed ID: 28478430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.